Neuro-Oncology Reviews
Volume
28 Number 12
30 April 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 12, 30 April
Das S, Goswami HR, Barman I,
Talukdar N.
Efficacy
of oncolytic viruses (OVs) in malignant tumor therapy: a review on
its therapeutic aspects.
Clin
Chim Acta.
2026 Apr 21;589:121017. doi:
10.1016/j.cca.2026.121017. PMID:
42025901˰
ˍ
Wisdom AJ, Temple H, Cui Y, Del
Vecchio CT, Kim T, White FM, Floyd SR, Spranger S. Mechanisms,
Microenvironments,
and Models: Understanding Therapeutic Resistance in Glioblastoma.
Int
J Radiat Oncol Biol Phys.
2026 Apr 22:S0360-3016(26)00587-0. doi:
10.1016/j.ijrobp.2026.04.013. PMID:
42031225. ˍ
Greenland J, Kendrick J, Ebert MA, Mirzaei M, White R, Dass J,
Polpo A, Rowshanfarzad P.
Emerging
Outcome Trends From Proton Therapy for Pediatric CNS Tumors: A
Systematic Review.
Int
J Part Ther. 2026 Apr 23;20:101317. doi:
10.1016/j.ijpt.2026.101317. PMID:
42205855. ˍ
Pasqualetti F, Ius T, Montemurro
N, Bertolotti C, Pivato S, Padovan M, Caccese M, Bellu L, Morganti
R, Acerbi F, Denaro L, Soffietti R, Ottaviani D, Bocci G, Lombardi
G, Krengli M.
Prolonged
sequential temozolomide in glioblastoma: A systematic review with
exploratory quantitative synthesis.
Cancer
Treat Res Commun.
2026 Apr 27;47:101231. doi:
10.1016/j.ctarc.2026.101231. PMID:
42114299. ˍ
Nordahl IK, Johnstad C, Solheim O, Torp SH.
Ki-67
and overall survival in patients with glioblastoma: A systematic
prognostic review and meta-analysis.
Neurooncol
Adv. 2026 Apr 27;8(1):vdag111. doi:
10.1093/noajnl/vdag111. PMID:
42211396. ˍ
Arend RB, Sousa MP, Kieling DM,
Ribeiro FV, Peroni BZ, Lima NL, Carretta LT, Cabral Junior SG,
Simoni G, Camerotte R, Ferreira MY, Kieling LM, Wouters K,
Palavani LB, Roman A, Gago G, Formentin C, Brito HN.
Efficacy
and safety of gamma knife radiosurgery in the management of
pediatric gliomas: a systematic review and meta-analysis.
J
Neurosurg Sci.
2026 Apr 28. doi:
10.23736/S0390-5616.26.06777-9. PMID:
42047998˰
ˍ
Bennett J, Bouffet E.
From
blunt tools to bullseyes: The impact of targeted therapy in
pediatric neuro-oncology.
Neurooncol
Adv. 2026 Apr
28;8(Suppl 2):ii1-ii3. doi:
10.1093/noajnl/vdaf262. PMID:
42059001. ˍ